Status:
RECRUITING
Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL)
Lead Sponsor:
Technische Universität Dresden
Conditions:
Acute Myeloid Leukemia (AML)
Eligibility:
All Genders
18+ years
Brief Summary
This is a registry study in adult patients with newly diagnosed or refractory/relapsed acute myeloid leukemia. Investigator's sites: 51 sites in Germany. Primary objectives: * Identification of epi...
Detailed Description
see brief summary
Eligibility Criteria
Inclusion
- AML according to the WHO (World Health Organization) diagnostic criteria, including acute promyelocytic leukemia
- Age ≥ 18 years. There is no upper age limit.
- Signed written informed consent
Exclusion
- there are no exclusion criteria
Key Trial Info
Start Date :
September 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2030
Estimated Enrollment :
15000 Patients enrolled
Trial Details
Trial ID
NCT03188874
Start Date
September 1 2010
End Date
September 30 2030
Last Update
April 18 2024
Active Locations (51)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Mittelbaden
Baden-Baden, Baden-Wurttemberg, Germany, 76532
2
Universtitätsklinikum Heidelberg
Heidelberg, Baden-Wurttemberg, Germany, 69120
3
Klinikum Mannheim GmbH
Mannheim, Baden-Wurttemberg, Germany, 68167
4
Diakonie-Klinikum
Schwäbisch Hall, Baden-Wurttemberg, Germany, 74523